Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Arrowhead Pharmaceuticals (ARWR) over the last 14 years, with Sep 2025 value amounting to -$13.0 million.

  • Arrowhead Pharmaceuticals' Other Working Capital Changes fell 695.12% to -$13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 343.71%. This contributed to the annual value of $9.9 million for FY2025, which is 343.71% up from last year.
  • As of Q3 2025, Arrowhead Pharmaceuticals' Other Working Capital Changes stood at -$13.0 million, which was up 35.73% from -$20.3 million recorded in Q2 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Other Working Capital Changes ranged from a high of $259.7 million in Q1 2021 and a low of -$76.2 million during Q1 2023.
  • For the 3-year period, Arrowhead Pharmaceuticals' Other Working Capital Changes averaged around -$8.5 million, with its median value being -$1.6 million (2024).
  • Per our database at Business Quant, Arrowhead Pharmaceuticals' Other Working Capital Changes crashed by 75,639.12% in 2022 and then spiked by 7,093.24% in 2025.
  • Arrowhead Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at $30,420 in 2021, then crashed by 75,639.12% to -$23.0 million in 2022, then surged by 116.52% to $3.8 million in 2023, then tumbled by 136.93% to -$1.4 million in 2024, then crashed by 695.12% to -$13.0 million in 2025.
  • Its Other Working Capital Changes stands at -$13.0 million for Q3 2025, versus -$20.3 million for Q2 2025 and $44.7 million for Q1 2025.